April 7, 2022 -- Life sciences company Mission Bio has announced the appointment of Dr. Todd Druley, PhD, as chief medical officer (CMO), a newly created role at Mission Bio.
Druley brings to the role his vast experience in molecular diagnostics and building clinical programs, the company said in a press release. Prior to joining Mission Bio, Druley held CMO roles at Angle Biosciences and ArcherDX. He is also currently a scientific advisor for RhoDx.
Since 2016, he has also worked with Mission Bio's Tapestry Platform, the company's multi-omics platform that can analyze DNA and protein simultaneously from the same sample at single-cell resolution.